共 63 条
[6]
Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis
[J].
ANTI-CANCER DRUGS,
2006, 17 (05)
:587-595
[8]
Beretta G. L., ANTHRACYCLINE CHEM B, V283, P1
[10]
Chalati T, 2011, NANOMEDICINE-UK, V6, P1683, DOI [10.2217/NNM.11.69, 10.2217/nnm.11.69]